Astemizole

API STANDARDS

Product Details

CAT No.# CS-O-11602
Category API Standards
CAS 68844-77-9
Molecular Weight 458.57
Molecular Formula C28H31FN4O
Stock Status: In-Stock
Purity: >98%
Melting Point: >175
Solubility: Chloroform, Methanol
Appearance: White Solid
Synonyms: 1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine
Application Notes: Nonsedating-type histamine H1-receptor antagonist. Potential for combination therapy with antivancer drugs such as doxorubicin in resistant leukemia. Antihistaminic.
References: Wauquier, A., et al.: Eur. J. Pharmacol., 72, 245 (1981), Laduron, P.M., et al.: Mol. Pharmacol., 21, 294 (1982), Richards, D.M., et al.: Drugs, 28, 38 (1984), Al-Obaid, A.M., et al.: Anal. Profiles Drug Subs., 20, 173 (1991), Ishikawa, M., et al.: Biol.
Storage: 2-8°C
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. 3-bromo-2,2-dimethyl-butane
3. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
4. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
5. Benidipine D7
6. Lauroside D
7. Triazolam 13C D3
8. Icatibant impurity 1
9. BISPHENOL AF (RING-13C12)
10. 0.1% TFA in Water ULC-MS
11. Metamizole EP Impurity C HCl
12. Silodosin Metabolite D4
13. Brivaracetam Carboxylic acid metabolite [UCB 42145]
14. Terbuthylazine D5
15. tibolone (848)
16. (Z)-Dimethylvinphos
17. Silodosin Metabolite
18. 2-Phenoxymethanesulfonanilide
19. Nimesulide EP Impurity A
20. Acetone HPLC


SMILES:
FC1=CC=C(C=C1)CN2C(C=CC=C3)=C3N=C2NC4CCN(CCC5=CC=C(OC)C=C5)CC4



This page contains information about Astemizole Cas 68844-77-9 and its API Standards.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."